GRIFOLS USA LLC
Entity uei:D48FNWJCJ5H5 · UEI D48FNWJCJ5H5
Obligations by fiscal year
Awards (5)
| 36C26024F0023↗ PROLASTIN-C | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | Oct 1, 2023 – Sep 30, 2024 | $289K | — | 0 |
| 36C26024F0409↗ PROLASTIN LIQUID | Department of Veterans Affairs Department of Veterans Affairs | FY2024 | May 20, 2024 – Sep 30, 2024 | $157K | — | 0 |
| 36C26026F0015↗ PHARM - PROLASTIN-C | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Oct 1, 2025 – Sep 30, 2026 | $120K | — | 0 |
| 36C26026F0019↗ PHARM - PROLASTIN-C | Department of Veterans Affairs Department of Veterans Affairs | FY2026 | Oct 1, 2025 – Sep 30, 2026 | $111K | — | 0 |
| 36C26325F0017↗ PHARMACEUTICALS | Department of Veterans Affairs Department of Veterans Affairs | FY2025 | Oct 11, 2024 – Sep 30, 2025 | $103K | — | 0 |
Observed spellings (1)
Raw recipient names from source records that resolved to this entity.
- GRIFOLS USA LLC
D48FNWJCJ5H5· seen 15×